Related references
Note: Only part of the references are listed.Use of molecular markers for predicting therapy response in cancer patients
Michael J. Duffy et al.
CANCER TREATMENT REVIEWS (2011)
Use of faecal markers in screening for colorectal neoplasia: a European group on tumor markers position paper
Michael J. Duffy et al.
INTERNATIONAL JOURNAL OF CANCER (2011)
Effect of Screening on Ovarian Cancer Mortality The Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Randomized Controlled Trial
Saundra S. Buys et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2011)
CA 15-3: Uses and limitation as a biomarker for breast cancer
Michael J. Duffy et al.
CLINICA CHIMICA ACTA (2010)
Biologically Targeted Cancer Therapy and Marginal Benefits: Are We Making Too Much of Too Little or Are We Achieving Too Little by Giving Too Much?
Tito Fojo et al.
CLINICAL CANCER RESEARCH (2010)
National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines for Use of Tumor Markers in Liver, Bladder, Cervical, and Gastric Cancers
Catharine M. Sturgeon et al.
CLINICAL CHEMISTRY (2010)
American Society of Clinical Oncology Clinical Practice Guideline on Uses of Serum Tumor Markers in Adult Males With Germ Cell Tumors
Timothy D. Gilligan et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Early versus delayed treatment of relapsed ovarian cancer (MRC OV05/EORTC 55955): a randomised trial
Gordon J. S. Rustin et al.
LANCET (2010)
Pharmacogenetics and Pharmacogenomics of Anticancer Agents
R. Stephanie Huang et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2009)
Sensitivity and specificity of multimodal and ultrasound screening for ovarian cancer, and stage distribution of detected cancers: results of the prevalence screen of the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS)
Usha Menon et al.
LANCET ONCOLOGY (2009)
Mortality Results from a Randomized Prostate-Cancer Screening Trial
Gerald L. Andriole et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Screening and Prostate-Cancer Mortality in a Randomized European Study
Fritz H. Schroeder et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines for Use of Tumor Markers in Testicular, Prostate, Colorectal, Breast, and Ovarian Cancers
Catharine M. Sturgeon et al.
CLINICAL CHEMISTRY (2008)
American society of clinical oncology 2007 update of recommendations for the use of tumor markers in breast cancer
Lyndsay Harris et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
American Society of Clinical Oncology 2007 Update of Recommendations for the Use of Tumor Markers in Breast Cancer
[Anonymous]
JOURNAL OF ONCOLOGY PRACTICE (2007)
Tumour markers in colorectal cancer: European Group on Tumour Markers (EGTM) guidelines for clinical use
M. J. Duffy et al.
EUROPEAN JOURNAL OF CANCER (2007)
Role of tumor markers in patients with solid cancers: A critical review
Michael J. Duffy
EUROPEAN JOURNAL OF INTERNAL MEDICINE (2007)
Variation in the definition of biochemical recurrence in patients treated for localized prostate cancer: The American Urological Association Prostate Guidelines for Localized Prostate Cancer update panel report and recommendations for a standard in the reporting of surgical outcomes
Michael S. Cookson et al.
JOURNAL OF UROLOGY (2007)
ASCO 2006 update of recommendations for the use of tumor markers in gastrointestinal cancer
Gershon Y. Locker et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Effect of surgeon specialty on processes of care and outcomes for ovarian cancer patients
CC Earle et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2006)
Ovarian cancer screening in the Prostate, Lung, Colorectal and Ovarian (PLCO) cancer screening trial: Findings from the initial screen of a randomized trial
SS Buys et al.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2005)
Management of hepatoceullular carcinoma
J Bruix et al.
HEPATOLOGY (2005)
CA125 in ovarian cancer: European Group on Tumor Markers guidelines for clinical use
MJ Duffy et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2005)
Definitions of biochemical failure that best predict clinical failure in patients with prostate cancer treated with external beam radiation alone: A multi-institutional pooled analysis
EM Horwitz et al.
JOURNAL OF UROLOGY (2005)
Predictive markers in breast and other cancers: A review
MJ Duffy
CLINICAL CHEMISTRY (2005)
Tumor markers in breast cancer - European Group on Tumor Markers recommendations
R Molina et al.
TUMOR BIOLOGY (2005)
Prostate-specific antigen:: A review of the validation of the most commonly used cancer biomarker
J Hernández et al.
CANCER (2004)
A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer
S Paik et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Follow-up of patients with curatively resected colorectal cancer: a practice guideline
A Figueredo et al.
BMC CANCER (2003)
Clinical utility of biochemical markers in colorectal cancer: European Group on Tumour Markers (EGTM) guidelines
MJ Duffy et al.
EUROPEAN JOURNAL OF CANCER (2003)
Impact on survival of intensive follow up after curative resection for colorectal cancer: systematic review and meta-analysis of randomised trials
AG Renehan et al.
BMJ-BRITISH MEDICAL JOURNAL (2002)
Pooled analysis of prognostic impact of urokinase-type plasminogen activator and its inhibitor PAI-1 8377 breast cancer patients
MP Look et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2002)
Randomized adjuvant chemotherapy trial in high-risk, lymph node-negative breast cancer patients identified by urokinase-type plasminogen activator and plasminogen activator inhibitor type 1
F Jänicke et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2001)
Serum tumour marker CA 125 in monitoring of ovarian cancer during first-line chemotherapy
MK Tuxen et al.
BRITISH JOURNAL OF CANCER (2001)
Share Paper
